Showing results (111-120 of 130) with videos related to
Sort By:
Pageof 13
European Journal of Neurology|October 10, 2023
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndromePieter A van Doorn, Peter Y K Van den Bergh, Robert D M Hadden, et al.Plos One|March 9, 2023
Contactin-1 links autoimmune neuropathy and membranous glomerulonephritisJanev Fehmi, Alexander J Davies, Marilina Antonelou, et al.Brain : a Journal of Neurology|April 21, 2021
Antibodies to the Caspr1/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathyElba Pascual-Goñi, Janev Fehmi, Cinta Lleixà, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 6, 2020
Serum neurofilament light chain predicts long-term prognosis in Guillain-Barré syndrome patientsLorena Martín-Aguilar, Pol Camps-Renom, Cinta Lleixà, et al.Journal of Neuroinflammation|November 1, 2021
Autoantibody screening in Guillain-Barré syndromeCinta Lleixà, Lorena Martín-Aguilar, Elba Pascual-Goñi, et al.Neurology|February 20, 2020
Clinical and therapeutic features of myasthenia gravis in adults based on age at onsetElena Cortés-Vicente, Rodrigo Álvarez-Velasco, Sonia Segovia, et al.Neurology(R) Neuroimmunology & Neuroinflammation|September 7, 2023
mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple SclerosisYolanda Blanco, Domingo Escudero, Cinta Lleixà, et al.European Journal of Neurology|March 15, 2021
Clinical characteristics and outcomes of thymoma-associated myasthenia gravisRodrigo Álvarez-Velasco, Gerardo Gutiérrez-Gutiérrez, Juan Carlos Trujillo, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|November 9, 2018
Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosisNoelia Villarrubia, Eulalia Rodríguez-Martín, Elisenda Alari-Pahissa, et al.Molecular Genetics and Metabolism|August 6, 2019
Study of the effect of anti-rhGAA antibodies at low and intermediate titers in late onset Pompe patients treated with ERTEsther Fernández-Simón, Ana Carrasco-Rozas, Eduard Gallardo, et al.Pageof 13